In part I, Professor David Sanders will discuss scientific aspects of the vaccines and SARS-COV-2 and explain how the various vaccine technologies are designed to defend against SARS-COV-2 infection.
In Part II, Eyal H. Barash, will discuss the regulatory framework behind the Emergency Use Authorization and how it differs from the approval of a pharmaceutical product. There will be a Q&A session after their presentation.